NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-144-2019-0-US-01 Treatment And Prevention Of Neuropathic Pain With P2Y14 Antagonists US 62/877,385 Abandoned
NHLBI E-055-2019-1-US-01 ApoE-ApoCII Chimeric Peptides US 62/876,923 Abandoned
NICHD E-247-2009-2-IL-10 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes IL DIV 268181 Issued
NHLBI E-134-2017-3-NZ-14 ApoC-ll Mimetic Peptides NZ National Stage 755599 Issued
NCI E-181-2019-0-US-01 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains US 62/876,483 Abandoned
NCI E-495-2013-0-CN-18 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS CN DIV 201910649441.7 Issued
NHLBI E-134-2017-3-US-02 ApoC-II Mimetic Peptides US National Stage 16/479,183 11136372 Issued PDF
NCI E-266-2011-0-IL-36 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IL DIV 268157 Issued
NEI E-164-2018-3-PCT-01 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS PCT PCT COMB PCT/US2019/042365 Expired
NINDS E-088-2018-1-US-12 HERV-K Antibody For Treatment Of ALS US National Stage 16/478,576 10723787 Issued PDF
NCI E-171-2018-9-US-04 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/513,933 Abandoned
NHGRI E-164-2020-2-PCT-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS PCT PCT COMB PCT/US2019/042073 Expired
NHGRI E-164-2020-3-US-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS US CIP 16/513,576 Pending
NHGRI E-164-2020-2-CN-03 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS CN National Stage 201980057936.9 Pending
NHGRI E-044-2013-1-HK-17 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA HK EP 19126894.5 Pending
NHGRI E-164-2020-2-EP-09 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS EP National Stage 19749899.1 Pending
NHGRI E-164-2020-2-JP-11 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS JP National Stage 2021-526207 Pending
NHGRI E-164-2020-2-MX-07 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS MX National Stage MX/A/2021/000638 Pending
NHGRI E-164-2020-2-BR-06 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS BR National Stage BR112021000675-3 Pending
NHGRI E-164-2020-2-AU-02 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS AU National Stage 2019304992 Pending
NHGRI E-164-2020-2-KR-05 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS KR National Stage 10-2021-7004181 Pending
NHGRI E-164-2020-2-IN-10 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS IN National Stage 202117002972 Pending
NHGRI E-164-2020-2-IL-04 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS IL National Stage 2047-01-28 Pending
NHGRI E-164-2020-2-CA-08 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS CA National Stage 3106640 Pending
NEI E-094-2016-0-US-03 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY US National Stage 16/478,093 11819020 Issued PDF
NCI E-011-2019-1-PCT-01 Cell Linkers for Heterotypic Cell Spheroids PCT PCT PCT/US2019/041800 Expired
NHLBI E-146-2019-0-US-01 HIGH RELAXIVITY MULITIVALENT GADOLINIUM ON A PEPTIDE SCAFFOLD US 62/873,272 Abandoned
NCI E-161-2018-0-JP-06 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF JP National Stage 2021-500651 Issued
NCI E-053-2015-1-FR-14 MYC G-Quadruplex Stabilizing Small Molecules and Their Use FR EP 19185807.5 Issued
NCI E-053-2015-1-DE-13 MYC G-Quadruplex Stabilizing Small Molecules and Their Use DE EP 19185807.5 Issued
NCI E-053-2015-1-CH-12 MYC G-Quadruplex Stabilizing Small Molecules and Their Use CH EP 19185807.5 Issued
NCI E-053-2015-1-GB-15 MYC G-Quadruplex Stabilizing Small Molecules and Their Use GB EP 19185807.5 Issued
NCI E-053-2015-1-EP-05 MYC G-Quadruplex Stabilizing Small Molecules and Their Use EP DIV 19185807.5 Issued
NCI E-154-2018-0-PCT-02 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2019/041464 Expired
NCI E-161-2018-0-PCT-02 Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development PCT PCT PCT/US2019/041401 Expired
NCI E-161-2018-0-EP-05 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF EP National Stage 19746264.1 Pending
NCI E-154-2018-0-EP-04 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME EP National Stage 19746275.7 Pending
NCI E-154-2018-0-JP-05 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME JP National Stage 2021-500734 Issued
NCI E-161-2018-0-AU-03 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF AU National Stage 2019301675 Pending
NCI E-154-2018-0-CA-03 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME CA National Stage 3106008 Pending
NCI E-161-2018-0-CA-04 Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development CA National Stage 3105694 Pending
NIBIB E-122-2019-0-US-01 METAL-ORGANIC FRAMEWORK FOR SINGLE-STRANDED NUCLEIC ACID EXTRACTION US 62/872,429 Abandoned
NLM E-111-2016-7-HK-07 Novel CRISPR Enzymes And Systems HK National Stage 19126548.7 Pending
NLM E-110-2016-2-HK-07 Novel CRISPR Enzymes And Systems HK National Stage 19126549.5 Pending
NIBIB E-005-2012-3-US-11 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US National Stage 16/475,508 11086113 Issued PDF
NIAID E-004-2009-2-EP-18 Viral Like Particle Compositions and Methods of Use EP DIV 19183770.7 Pending
NCI E-103-2019-0-US-01 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE US 62/869,956 Abandoned
NCI E-247-2015-0-US-07 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA US DIV 16/459,396 11111306 Issued PDF
NCI E-184-2009-0-US-21 Combination Immunotherapy Compositions And Methods US CON 16/458,726 10874729 Issued PDF
NCI E-213-2018-0-IN-08 TRITERPENE AMINE DERIVATIVES IN National Stage 202037051582 Issued